DG Armed Forces Medical Service Diltiazem 60 mg Tablet Tender 2026

Tender Overview

Organization: DG Armed Forces Medical Service (Department of Defence). The procurement concerns Diltiazem 60 mg tablets under a government supply contract. The scope is limited to the supply of Goods with no BOQ items published. Eligibility highlights include a focus on 3 years of experience in supplying similar Category Products to Central/State Government or PSUs, and a minimum turnover criterion over the last three financial years. An OEM authorization is required when bidding via authorized distributors. A notable option clause allows a ±25% quantity variation and an extended delivery window with a minimum 30 days, under contracted rates. The tender emphasizes non-toxicity and potential MSDS provision for toxic materials, with GST handling left to bidder responsibility. This tender is oriented to suppliers meeting government procurement norms and demonstrated past performance.

Key differentiators include compliance with government turnover and experience criteria, the need for OEM/authorised dealer documentation, and the 25% quantity option and extension mechanism that affects delivery planning. The opportunity lacks a public BOQ and explicit price estimates, signaling a focus on credible supplier capability and compliance rather than bid-driven price competition.

Keywords: tender in Defence procurement, Diltiazem tablets tender, government health supplies, OEM authorization requirement.